One year before Second Sight Medical (NSDQ:EYES) netted more than $36 million from its initial public offering, company CEO Dr. Robert Greenberg sat down with MassDevice.com for a long ranging interview about the 22 year journey to bring the "bionic eye" to life.
Click on the audio player below to listen to this interview in full: